Mind Medicine Inc (NASDAQ: MNMD) kicked off on Tuesday, up 5.41% from the previous trading day, before settling in for the closing price of $13.3. Over the past 52 weeks, MNMD has traded in a range of $4.70-$14.43.
Healthcare Sector giant saw their annual sales surged by 12.11% over the last five years. While this was happening, its average annual earnings per share was recorded -32.79%. With a float of $73.33 million, this company’s outstanding shares have now reached $76.77 million.
The firm has a total of 74 workers. Let’s measure their productivity.
Mind Medicine Inc (MNMD) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Mind Medicine Inc is 2.94%, while institutional ownership is 51.75%. The most recent insider transaction that took place on Sep 25 ’25, was worth 110,186. In this transaction Chief Legal Officer of this company sold 11,278 shares at a rate of $9.77, taking the stock ownership to the 293,852 shares. Before that another transaction happened on Sep 25 ’25, when Company’s Chief Executive Officer sold 25,797 for $9.77, making the entire transaction worth $252,037. This insider now owns 804,268 shares in total.
Mind Medicine Inc (MNMD) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.41 earnings per share (EPS), lower than consensus estimate (set at -0.28) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -32.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.86% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Take a look at Mind Medicine Inc’s (MNMD) current performance indicators. Last quarter, stock had a quick ratio of 3.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.97, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.80 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Analysing the last 5-days average volume posted by the [Mind Medicine Inc, MNMD], we can find that recorded value of 3.37 million was better than the volume posted last year of 1.62 million. As of the previous 9 days, the stock’s Stochastic %D was 75.11%.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 92.99%, which indicates a significant increase from 89.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.72 in the past 14 days, which was lower than the 0.73 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.30, while its 200-day Moving Average is $9.14. Now, the first resistance to watch is $14.37. This is followed by the second major resistance level at $14.73. The third major resistance level sits at $15.17. If the price goes on to break the first support level at $13.57, it is likely to go to the next support level at $13.13. Should the price break the second support level, the third support level stands at $12.77.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
The company with the Market Capitalisation of 1.38 billion has total of 98,509K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -108,680 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -67,270 K.
